NCT03414723View on ClinicalTrials.gov

A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

March 10, 2018

Study Completion Date

March 10, 2018

Conditions
Diabetes MellitusHealthy Subjects
Interventions
DRUG

Sotagliflozin (SAR439954)

"Pharmaceutical form: tablets~Route of administration: oral"

DRUG

Ramipril

"Pharmaceutical form: tablets~Route of administration: oral"

Trial Locations (1)

14050

Investigational Site Number 2760001, Berlin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY